前视内镜在Billroth II胃切除术后患者ERCP中的应用:系统评价与Meta分析
该系统评价与Meta分析纳入25项研究共2446例Billroth II胃切除术后行ERCP的患者,比较前视内镜(499例)与侧视内镜(1947例)的疗效与安全性。结果显示前视内镜的输入袢插管率较高(90.3% vs 86.8%),但选择性插管率略低(91.1% vs 92.3%),穿孔率较低(3.0% vs 3.6%),而胰腺炎率(5.4% vs 2.5%)和出血率(3.0% vs 2.0%)较高。结论认为前视内镜与侧视内镜在Billroth II胃切除术后ERCP中同样安全有效。
要点
- 前视内镜输入袢插管率90.3%,高于侧视内镜的86.8%。
- 侧视内镜选择性插管率92.3%,略高于前视内镜的91.1%。
- 前视内镜胰腺炎率5.4%、出血率3.0%,均高于侧视内镜。
核心结论
- 前视内镜在Billroth II胃切除术后ERCP中与侧视内镜同样安全有效。
研究设计与样本
- 系统评价与Meta分析,纳入25项研究(1项随机、18项回顾、1项前瞻、5项病例系列),共2446例患者。
主要发现
- 前视内镜输入袢插管率90.3%(95%CI 85.6-93.6),侧视内镜86.8%(95%CI 82.8-89.9)。
- 侧视内镜选择性插管率92.3%(95%CI 88.0-95.2),前视内镜91.1%(95%CI 87.2-93.9)。
- 侧视内镜穿孔率3.6%(95%CI 2.3-5.7),前视内镜3.0%(95%CI 1.7-5.3)。
- 前视内镜胰腺炎率5.4%(95%CI 3.6-8.0),侧视内镜2.5%(95%CI 2.3-5.7)。
- 前视内镜出血率3.0%(95%CI 1.6-5.5),侧视内镜2.0%(95%CI 1.4-3.0)。
临床怎么用
- Billroth II胃切除术后需行ERCP时,前视内镜可作为与侧视内镜等效的安全选择。
局限性
- 纳入研究以回顾性为主,仅1项随机研究,方法学质量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The forward-viewing endoscope has been increasingly used to perform endoscopic retrograde cholangiopancreatography (ERCP) in patients who underwent Billroth II gastrectomy. This study intended to assess efficacy and safety of the forward-viewing endoscope for ERCP in Billroth II gastrectomy patients compared with conventional side-viewing endoscope using a systematic review and meta-analysis. METHODS: A systematic review was conducted for studies that evaluated the outcomes of ERCP for patients with Billroth II gastrectomy. Random-effect model meta-analyses with subgroup analyses were conducted. The methodological quality of the included publications was evaluated using the risk of bias assessment tool for non-randomized studies. The publication bias was assessed. RESULTS: In total, 25 studies (1 randomized, 18 retrospective, 1 prospective, and 5 case series studies) with 2446 patients (499 forward-viewing and 1947 side-viewing endoscopes) were analyzed. The pooled afferent loop intubation rate was higher with the forward-viewing endoscope (90.3%, 95% confidence interval (CI) 85.6-93.6 vs. 86.8%, 95% CI 82.8-89.9%). The pooled selective cannulation rate was higher with the side-viewing endoscope (92.3%, 95% CI 88.0-95.2 vs. 91.1%, 95% CI 87.2-93.9%). The pooled bowel perforation rate was higher with the side-viewing endoscope (3.6%, 95% CI 2.3-5.7 vs. 3.0%, 95% CI 1.7-5.3%). The pooled pancreatitis rate was higher with the forward-viewing endoscope (5.4%, 95% CI 3.6-8.0 vs. 2.5%, 95% CI 2.3-5.7%). The pooled bleeding rate was higher with the forward-viewing endoscope (3.0%, 95% CI 1.6-5.5 vs. 2.0%, 95% CI 1.4-3.0%). The heterogeneity among the studies was not significant. The publication bias was minimal. CONCLUSION: This meta-analysis indicates that the forward-viewing endoscope is as safe and effective as conventional side-viewing endoscope for ERCP in patients with Billroth II gastrectomy.
引用
- Park TY, Bang CS, Choi SH, et al. Forward-viewing endoscope for ERCP in patients with Billroth II gastrectomy: a systematic review and meta-analysis. Surg Endosc. 2018. PMID: 29777352. doi:10.1007/s00464-018-6213-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。